Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.

[1]  Paul Aurora,et al.  Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report--2007. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  A. Rahmel,et al.  Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric heart transplantation report--2008. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  K. Trinkaus,et al.  Surveillance for transplant coronary artery disease in infant, child and adolescent heart transplant recipients: an intravascular ultrasound study. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  J. Wald,et al.  Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin , 2006, Clinical transplantation.

[5]  M. Pescovitz.  Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  S. Webber,et al.  Anti‐HLA alloantibodies in pediatric solid organ transplantation , 2006, Pediatric transplantation.

[7]  S. Webber,et al.  18: Survival in allosensitized children after listing for heart transplantation , 2006 .

[8]  K. Mussatto,et al.  The virtual crossmatch – A screening tool for sensitized pediatric heart transplant recipients , 2006, Pediatric transplantation.

[9]  M. Fishbein,et al.  Acute antibody-mediated rejection of cardiac transplants. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  W. Mahle,et al.  Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing. , 2005, The Journal of thoracic and cardiovascular surgery.

[11]  J. Jacobs,et al.  Pediatric cardiac transplantation in children with high panel reactive antibody. , 2004, The Annals of thoracic surgery.

[12]  P. Nickerson,et al.  National Conference to Assess Antibody‐Mediated Rejection in Solid Organ Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  J. Kirklin,et al.  Late rejection episodes more than 1 year after pediatric heart transplantation: risk factors and outcomes. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  D. McKenna,et al.  HLA alloimmunization in patients requiring ventricular assist device support. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  C. Canter,et al.  Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: a multi-institutional study. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  L. Lambert,et al.  Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. , 2000, The Journal of thoracic and cardiovascular surgery.

[17]  R. Hruban,et al.  Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. , 1999, Transplantation.

[18]  J. A. Robinson,et al.  Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  M. Oz,et al.  Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. , 1998, Circulation.

[20]  J. Kirklin,et al.  Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  J. Kobashigawa,et al.  Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation? , 1996, Circulation.

[22]  M. Yacoub,et al.  The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. , 1993, Transplant immunology.

[23]  D. Renlund,et al.  OUTCOME OF CARDIAC TRANSPLANT RECIPIENTS WITH A POSITIVE DONOR‐SPECIFIC CROSSMATCH—PRELIMINARY RESULTS WITH PLASMAPHERESIS , 1992, Transplantation.

[24]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[25]  Marshall I Hertz,et al.  Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  J. Saffitz,et al.  Non-ischemic left ventricular dysfunction after pediatric cardiac transplantation: treatment with plasmapheresis and OKT3. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  L. Bailey,et al.  The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation. , 2000, Journal of the American College of Cardiology.

[28]  M. Masek,et al.  Reliability and usefulness of immunofluorescence in heart transplantation. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  T. Spray,et al.  Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  Wayne Nelson,et al.  Graphical Analysis of System Repair Data , 1988 .